Is Array Uzf Stock Good For Portfolio Price At 17.71 Down 0.67 20260406 Is Crown Cck Stock Breaking Out Price At 100.97 Down 2.18 20260408 Is Cid Holdco Daic Stock A Good Buy In 2026 Price At 0.18 Up 1.66 20260406 Jim Cramer Highlights Xometrys Growth What It Signals for the Manufacturing Marketplace Wipro Sets June 5 Record Date for 15000 Crore Share Buyback at 250 Per Share Egypt Inks Landmark Deal to Export Cypriot Natural Gas to Europe via QatarEnergy UK PM Starmer Urges TNT Sports to Offer Champions League Final FreetoAir Goldman Sachs Latest US Sanctions on Russia Have Limited Impact on Crude Exports Micron Technology Breaches 1 Trillion Market Cap on AIDriven Memory Demand Surge CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates CPSS Q4 2025 Earnings EPS Misses Consensus Amidst Challenging Auto Finance Environment Lightbridge Corporation LTBR Q1 2026 Earnings Net Loss of 020 Per Share Continues Development Phase Firefly Neuroscience AIFF Q3 1998 Earnings Heavy Loss Surprises Analysts Yet Stock Rises DoubleVerify Q1 2026 Earnings EPS Misses Estimates Stock Declines New America Acquisition I Corp NWAX Holds Steady Near 1013 as Trading Volumes Remain Subdued AiRWA Inc YYAI Faces Mild Pullback Amid Sector Rotation Key Support Tested Generac Holdings GNRC Surges 7 as Energy Resilience Demand Gains Momentum Disc Medicine Inc IRON Gains as Shares Hold Above Key Support Level EPower Inc EPOW Edges Higher Tests Key Resistance at 070 BRFH Q1 2026 Earnings Narrowing Loss Beats Expectations as Cost Controls Take Effect Stem Inc STEM Q1 2026 Earnings Narrower Loss Drives Stock Higher Despite Revenue Discrepancy Nykaa Shares Surge to 52Week High Following Latest Quarterly Results HCWC Q4 2025 Earnings Narrowly Beats EPS Estimates Despite Ongoing BottomLine Loss Japanese Equities Surge as Nikkei 225 Climbs 274 at Close HYNE Q1 2026 Earnings Narrowing Losses Amid Quiet Quarter Glean CEO Arvind Jain Reveals Hiring Strategy Amid Thousands of Daily Applications WWW Q1 2026 Earnings EPS Exceeds Estimates Positive Market Response Dyne Therapeutics DYN Surges 587 as Biotech Momentum Builds